PFE
Pfizer Inc.
stock NYSE

i am new at the wheel and just trying out some trades with a smaller portfolio...
06/06 CC for PFE at 24 strike
and 6/27 CSP on Sofi at 12 strike
Both feel kind of pointless, but I am just trying to figure it all out

You can’t judge risk just by looking at payout. One thing I found out after years of investing is there certain securities that “the market” doesn’t like, hence their payout is higher. For example REITS, BDCs, MLPs. Of course you still have look at the individual securities and some are safer than others, but they all get tarred by the same brush. FWIW I also figured out there are some securities that the market likes, even though they are dogs IMHO. Someone posted about PFE (Pfizer) I own it and it has always been a dog, I need to sell it.

Well, I’m putting my limit at PFE. I think there is little risk that they decrease their payout, although it could fail to keep up with inflation and technically be reduced.
Usually, I would not go this high but it seems we’re in unusual times now. I’d keep around the 4-4.5% to be comfortable.

I maintain a barbell approach mixing growth and value/dividend payers. SCHD is one of my core ETF holdings, along with HDV, VYMI, SCHG, VOO, AVUV, GLDM, SPYI, and XDTE. Of these, VOO, SCHD, VYMI, HDV, and GLDM are my largest positions in that order. For individual stocks I have:
Aerospace & Defense - LMT, RTX, ISMAY, GD, BAESY, DRS, AVAV, KTOS, RKLB
Consumer Staples- WMT, KO, PEP, MO, BTI
Consumer Discretionary- AMZN
Tech: AVGO, NVDA, PLTR, CRWD, TSM, CYBR
Trading Houses and Distributors- MARUY
Utilities- NEE, SO, VST
Energy- ET, EPD, WES
O&G- CVX, CNQ, EOG
Healthcare- GILD, PFE, BMY
REITS - O

I'm going to break down this trade in real simple terms.
\- New FDA board want cures
\- Intellia is **currently** curing patients with far better results than competitors who simply treat. Inc PFE and ALNY
\- Stock is under $1bn yet expects to net $5-$10bn imminently with their 3 drugs in Stage 3 trials.
\- New FDA commissioner wants to speed up "time to market for cures". Meaning they could be given a provisional license anyday.
\- The weekly and daily has bottomed, classic bull flag and MAs have crossed upwards.
\- $800m+ in cash, enough to take them to commercialisation.
\- 30% short
Summary: The name essentially trades for FREE, its data far surpasses that of any competitor. This isn't a hope and dream idea, the cures are real and happening as we speak. We've just witnessed "a name I won't mention" pump over 10,000% last week, you likely saw it plastered all over twitter.
We've seen the likes of TEM become inlay and most still aren't aware what they actually do, we've seen LLY and HIMS attract massive inflows even though most don't fully understand their business model.
**Why now and not the past 3-4 years, why is today different?**
Last week a news catalyst hit mainstream, Base Editing curing a 6 month year old baby from a rare genetic disease. This news received over 30m views and caused the whole Genomic sector to pop. It's the first time I've ever seen people who know little about the sector praise it and the "possibilities".
Problem is, it's a tough sector to buy into unless you have multiple degrees in the sector.
However, what's not hard to read is the headlines as they project the shift in healthcare and the $100's Billions up for grabs.
Most people will read that part and still not want to buy in, why? Mass pessimism as over 25% of all biotechs now trade below cash, an ATH. People are stuck with recency bias, they never expect this sector to move. Yet technicals, fundamentals, momentum and policy now all point to a new bull run.
Even if I'm wrong, there's no real data to send it lower. It has cash to 2027. It's literally just a matter of time until a catalyst full sends it.
See you at $20+ shortly.

idk why but i felt compelled to buy a 12/17/2027 PFE $30C LEAP. Just seemed dirt cheap.

Hmm well measles has outbreaks, new covid variant is hitting Asia, how we feel about PFE leaps? At the moment puts seems to be the play but I imagine if 🥭 drops the 🪱 it might jump.

I'm going to break down this trade in real simple terms.
\- New FDA board want cures
\- Intellia is **currently** curing patients with far better results than competitors who simply treat. Inc PFE and ALNY
\- Stock is under $1bn yet expects to net $5-$10bn imminently with their 3 drugs in Stage 3 trials.
\- New FDA commissioner wants to speed up "time to market for cures". Meaning they could be given a provisional license anyday.
\- The weekly and daily has bottomed, classic bull flag and MAs have crossed upwards.
\- $800m+ in cash, enough to take them to commercialisation.
Summary: The name essentially trades for FREE, its data far surpasses that of any competitor. This isn't a hope and dream idea, the cures are real and happening as we speak. We've just witnessed "a name I won't mention" pump over 10,000% last week, you likely saw it plastered all over twitter.
We've seen the likes of TEM become inlay and most still aren't aware what they actually do, we've seen LLY and HIMS attract massive inflows even though most don't fully understand their business model.
**Why now and not the past 3-4 years, why is today different?**
Last week a news catalyst hit mainstream, Base Editing curing a 6 month year old baby from a rare genetic disease. This news received over 30m views and caused the whole Genomic sector to pop. It's the first time I've ever seen people who know little about the sector praise it and the "possibilities".
Problem is, it's a tough sector to buy into unless you have multiple degrees in the sector.
However, what's not hard to read is the headlines as they project the shift in healthcare and the $100's Billions up for grabs.
Most people will read that part and still not want to buy in, why? Mass pessimism as over 25% of all biotechs now trade below cash, an ATH. People are stuck with recency bias, they never expect this sector to move. Yet technicals, fundamentals, momentum and policy now all point to a new bull run.
Even if I'm wrong, there's no real data to send it lower. It has cash to 2027. It's literally just a matter of time until a catalyst full sends it.
See you at $20+ shortly.

btc PFE Jun27'25 22 PUT @ 0.2 earlier today.
was sold for 0.45.
now have to find a new csp.

this is when PFE calls print for those that bought em.

Im also doing this with PFE & VZ. and planning on running in on WMT and KO once i have 100 shares of those. End goal is to do it with SPY weekly.

My main income-generating core is a mixer of ETFs and individual stocks: SCHD, HDV, VYMI, SPYI, XDTE, VOO, ET, EPD, WES, O, KO, LMT, RTX, GD, DRS, BAESY, ISMAY, CNQ, CVX, EOG, BMY, GILD, PFE, MO, BTI, NEE, SO, AVGO, GOOGL, PEP, MARUY, and WMT.

Time to buy PFE lol